Publication:
Enantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme.

dc.contributor.authorBorrego, Lorenzo G
dc.contributor.authorRecio, Rocío
dc.contributor.authorMoreno, Nazaret
dc.contributor.authorChelouan, Ahmed
dc.contributor.authorÁlvarez, Eleuterio
dc.contributor.authorSánchez-Coronilla, Antonio
dc.contributor.authorCaro, Carlos
dc.contributor.authorPearson, John R
dc.contributor.authorGarcía-Martín, Maria Luisa
dc.contributor.authorKhiar, Noureddine
dc.contributor.authorFernández, Inmaculada
dc.date.accessioned2023-05-03T14:56:36Z
dc.date.available2023-05-03T14:56:36Z
dc.date.issued2022-09-01
dc.description.abstractThe stereoselective addition of ethyl acetate enolate to the C═N bond of N-tert-butylsulfinylimines has been investigated in depth. A significant effect of the LHMDS amount and the N-sulfinylimine nature on the stereoselectivity of the process was observed. Conditions were found where sulfinylimines of differently substituted salicylaldehydes derivatives, ethyl acetate, and LHMDS afforded the corresponding addition products as a single diastereomer in good yields. The developed protocol was successfully applied to the first stereoselective synthesis of differently substituted 4-amino-3,4-dihydrocoumarin derivatives. Computational models confirmed the prominent role of the ortho aryl substituent in the stereoselectivity of the process. A significant and selective cytotoxic activity against Glioblastoma Multiforme (GBM) cancer line has been determined for the noncyclic hydroxy ester derivative.
dc.identifier.doi10.1016/j.ejmech.2022.114730
dc.identifier.essn1768-3254
dc.identifier.pmid36088758
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.ejmech.2022.114730
dc.identifier.urihttp://hdl.handle.net/10668/22187
dc.journal.titleEuropean journal of medicinal chemistry
dc.journal.titleabbreviationEur J Med Chem
dc.language.isoen
dc.organizationCentro Andaluz de Nanomedicina y Biotecnología-BIONAND
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number114730
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectEnantiopure 4-amino-3,4-dihydrocoumarins
dc.subjectGlioblastoma multiforme
dc.subjectN-sulfinylarylimines
dc.subjectβ-hydroxyesters
dc.subject.meshHumans
dc.subject.meshGlioblastoma
dc.subject.meshStereoisomerism
dc.subject.meshEsters
dc.subject.meshAntineoplastic Agents
dc.titleEnantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number243
dspace.entity.typePublication

Files